All posts
14550 total · page 39 of 291
Medical Device Industry Opposes India's Draft Regulatory Bill
India's medical device industry opposes a draft bill equating devices with drugs, citing potential harm to innovation and investment.
Molbio Diagnostics IPO: A Risky Opportunity for Long-Term Investors
Molbio Diagnostics seeks ₹200 crore through an IPO, aiming to reduce promoter stake and boost capital expenditures. Is it a high-risk, high-reward investment?
Indian Medical Device Sector Opposes Draft Bill on Regulatory Grounds
India's medical device industry contests a draft bill equating devices with pharmaceuticals, fearing impact on growth and innovation.
Price Caps on Private Healthcare May Hamper Growth, Warns Apollo MD
Apollo's Suneeta Reddy warns that price caps could deter private healthcare investment and innovation, amid government efforts to regulate costs.
Molbio Diagnostics Eyes ₹940 Crore Through IPO for Global Expansion
Molbio Diagnostics plans a ₹940 crore IPO to fund expansion and reduce promoter stake, seeking growth in global diagnostics markets.
Medical Device Industry Opposes Indian Draft Bill Over Pharma Treatment
India's medical device sector challenges a draft bill equating devices to drugs, citing regulatory and innovation concerns.
Molbio Diagnostics IPO Seeks ₹940 Crore Amidst Global Expansion
Molbio Diagnostics plans to raise ₹940 crore via IPO, targeting expansion and reducing promoter stake.
Medical Device Industry Rejects Pharma-Like Regulation in Draft Bill
India's medical device sector opposes the 2026 draft bill, arguing it wrongly equates devices with pharmaceuticals.
Apollo Hospitals Plans Major Expansion with 5,800 New Beds by 2031
Apollo Hospitals aims to add 5,800 beds in five years amid a 21% revenue increase to ₹7,043 crore in Q1 FY27.
Fortis Healthcare Shares Plummet 6% Amid Cost Regulation Proposal
Hospital stocks tumble as a parliamentary panel suggests capping private room rates to three-star hotel tariffs in metros.
Molbio Diagnostics Eyes ₹940 Crore Through IPO Amidst Global Expansion
Molbio Diagnostics plans to raise ₹940 crore via IPO to expand operations and reduce promoter stake.
Medical Device Industry Rejects Draft Bill, Cites Misclassification
India's medical device sector opposes the draft bill treating devices as drugs, citing innovation risks.
Unveiling the Strain: Living with Multiple Chronic Conditions
Managing multiple chronic conditions strains healthcare systems and patients alike, revealing gaps in care and support.
The Long-Term Health Impacts of Thyroid Disorders
Thyroid disorders often go unnoticed until they manifest severe symptoms, influencing long-term health.
Understanding Chronic Liver Disease: Causes, Risks, and Prevention
Chronic liver disease affects millions globally, linked to lifestyle and genetic factors. Prevention hinges on early diagnosis and lifestyle changes.
Arthritis: Navigating Daily Life with Chronic Pain
Arthritis affects millions, making everyday tasks challenging. Learn how it reshapes daily routines and the support available.
Managing Asthma Beyond the Inhaler: New Strategies and Solutions
Asthma treatment is evolving beyond inhalers, encompassing holistic approaches and new technologies.
Obesity: A Persistent Health Crisis Beyond the Scale
Obesity continues to challenge healthcare systems worldwide, demanding comprehensive strategies.
Recognizing Early Signs of Chronic Kidney Disease
Understanding early symptoms of Chronic Kidney Disease is vital for timely intervention and better outcomes.
Navigating Daily Life with Heart Disease: Strategies and Support
Living with heart disease requires daily adjustments and support from healthcare systems, yet offers opportunities for resilience and empowerment.
Hypertension: Unmasking the Silent Threat to Global Health
Hypertension often lurks unnoticed, affecting millions worldwide. Addressing this silent condition requires public awareness and proactive healthcare interventions.
Diabetes: Navigating the Challenges of Long-Term Health Management
Diabetes requires ongoing vigilance and innovation in care. New therapies and tech aim to improve quality of life.
Molbio Diagnostics Targets ₹940 Crore in IPO for Expansion and Stake Reduction
Molbio Diagnostics aims to raise ₹940 crore to expand operations and reduce promoter stake through its IPO. The company sees high growth potential in its diagnostic solutions.
Medical Device Industry Challenges Draft Bill Treating Devices as Drugs
India's medical device sector opposes a draft bill that equates devices with drugs, fearing impact on innovation and investment.
Molbio Diagnostics Targets ₹940 Crore in IPO for Expansion and Stake Reduction
Molbio Diagnostics plans to raise ₹940 crore through an IPO to fund expansion and reduce promoter stake, eyeing growth in global diagnostics.
Medical Device Industry Challenges Draft Bill on Regulatory Grounds
India's medical device sector opposes the Draft Bill 2026, arguing it treats devices like drugs, risking innovation and investments.
Molbio Diagnostics Seeks IPO to Fuel Global Expansion Amid Tuberculosis Test Success
Molbio Diagnostics plans to raise ₹940 crore via IPO to expand operations and reduce promoter stake, targeting high-risk investors.
Industry Pushback: Medical Devices Not Pharmaceuticals, Firms Say
Medical device firms oppose India's draft bill equating devices with drugs, citing risks to innovation and investment.
Molbio Diagnostics IPO: A High-Risk Bet for Long-Term Growth?
Molbio Diagnostics plans to raise ₹940 crore through its IPO to fund growth and reduce promoter stake.
India's Medical Device Industry Challenges Draft Bill's Pharma Approach
Medical device firms in India contest the 2026 draft bill treating devices like drugs, fearing it threatens innovation and investment.
Molbio Diagnostics Targets ₹940 Crore in IPO for Expansion
Molbio Diagnostics plans a ₹940 crore IPO to expand its manufacturing and reduce promoter stake.
Medical Device Industry Challenges Draft Bill Treating Devices as Drugs
India's medical device sector opposes a draft bill equating devices with drugs, citing potential harm to manufacturing and innovation.
Molbio Diagnostics Aims for Growth with ₹940 Crore IPO
Molbio Diagnostics plans a ₹940 crore IPO to fund expansion and reduce promoter stake, targeting high-risk investors.
Industry Pushback: Medical Devices Not Pharmaceuticals, Firms Oppose Bill
India's medical device sector opposes a draft bill equating devices with drugs, citing potential harm to innovation and investment.
Molbio Diagnostics Targets ₹940 Crore in IPO to Fuel Growth
Molbio Diagnostics seeks ₹200 crore for capital expansion and plans to reduce promoter stake via a ₹740 crore offer for sale.
Medical Device Industry Opposes Draft Bill Equating Devices with Drugs
India's medical device sector protests the draft bill, arguing it stifles innovation by treating devices like pharmaceuticals.
Molbio Diagnostics IPO: A High-Risk Bet for Long-Term Gains?
Molbio Diagnostics seeks ₹200 crore via IPO for expansion, targets ₹740 crore through promoter stake sale.
India's Medical Device Industry Challenges Draft Bill's Pharma Parallels
Industry voices argue the Draft Bill, equating medical devices with drugs, threatens innovation and investment.
Manipal Health IPO Sees Strong Institutional Demand, Oversubscribed
Manipal Health's IPO was oversubscribed, driven by strong institutional interest despite retail investor caution.
Major Legal Firms Guide Manipal Hospital’s INR 8000 Cr IPO
Leading law firms CAM, Khaitan, Latham, Trilegal, and JSA are advising Manipal Hospital on its INR 8000 crore IPO.
E-Cigarette Flavoring Vanillin Disrupts Stem Cell Development: UCR Study
Research shows vanillin in e-cigarettes impairs human embryonic stem cell growth, raising health concerns.
AI Technology Uncovers Cancer Stem Cells, Revolutionizes Treatment
New AI framework detects elusive cancer stem cells, paving the way for personalized medicine.
AI Identifies Cancer Stem Cells, Advancing Precision Medicine
AI has revealed hidden cancer stem cells linked to tumor recurrence, offering new paths for targeted treatments.
Himachal Pradesh Explores Gene Therapy, Phototherapy with US Collaboration
Himachal Pradesh government is advancing gene therapy and phototherapy initiatives through discussions with US medical experts.
PTC Therapeutics Acquires ST-920 to Boost Rare Disease Treatments
PTC Therapeutics expands its rare disease portfolio by acquiring ST-920, a promising Fabry disease treatment.
Taysha Gene Therapies Stock Declines Amid Investor Concerns
Taysha Gene Therapies' shares fell sharply today, driven by investor worries over recent financial disclosures.
Molbio Diagnostics Targets ₹940 Crore in IPO to Boost Global Reach
Molbio Diagnostics plans to raise ₹940 crore through an IPO to fund expansion and reduce promoter stake.
Moderate Coffee Intake Linked to Lower Cardiovascular Risk
Recent studies suggest moderate coffee consumption may reduce cardiovascular disease risk, shedding new light on the beverage's health effects.
Circadian Oncology: How Timing Influences Cancer Treatment Success
Research explores how aligning cancer treatments with the body's circadian rhythms can enhance patient outcomes.
India's Medical Device Sector Challenges Draft Bill's Pharma Alignment
Medical device firms protest India's draft bill equating devices to drugs, fearing innovation and investment setbacks.